International Perfusion Association

Social:

Facebook Instagram Linkedin
IPA

Day: January 7, 2024

Hypoxic Cell

Prospective Clinical Study Testing the Efficacy and Safety of a New Formula to Increase the Precision of Oxygen Therapy in the Initiation Phase of Cardiopulmonary Bypass

This study developed a formula for tailored oxygen therapy during cardiopulmonary bypass (CPB) to prevent cellular hypoxia and minimize the risk of hyperoxemia. In a pilot study, the formula aimed for a specific arterial partial oxygen pressure (PaO2) range, but only 38.75% of patients achieved the target range, indicating a need for further adjustments to the formula to enhance its effectiveness in guiding oxygen therapy during CPB.

READ MORE
January 7, 2024
VV ECMP

Post-COVID Changes in Lung Function 6 Months After Veno-Venous Extracorporeal Membrane Oxygenation: A Prospective Observational Clinical Trial

Six months after hospital discharge, patients with severe COVID-19 who received veno-venous extracorporeal membrane oxygenation (V-V ECMO) showed persistent impairments in small airway function and reduced respiratory tissue elasticity, compared to healthy controls. These findings indicate moderate but ongoing lung function impairment in severe acute COVID-19 cases, even after recovery from the critical phase of the infection.

READ MORE
January 7, 2024
COVID-19 Cost

Inpatient Costs of Treating Patients With COVID-19

This study analyzed the mean cost of inpatient care for COVID-19 patients in the US from March 2020 to March 2022, finding an overall increase from $10,394 to $13,072, with higher costs for patients with comorbidities like obesity and coagulation deficiency. The significant rise in costs, over five times the rate of medical inflation, was partly attributed to increased use of treatments like extracorporeal membrane oxygenation (ECMO) over time.

READ MORE
January 7, 2024

Post Categories